HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.

Abstract
The use of organophosphorus pesticides results in toxicity risk to non-target organisms. Organophosphorus compounds share a common mode of action, exerting their toxic effects primarily via acetylcholinesterase (AChE) inhibition. Consequently, acetylcholine accumulates in the synaptic clefts of muscles and nerves, leading to overstimulation of cholinergic receptors. Acute cholinergic crisis immediately follows exposure to organophosphate and includes signs and symptoms resulting from hyperstimulation of central and peripheral muscarinic and nicotinic receptors. The current view of the treatment of organophosphate poisoning includes three strategies, i.e. the use of an anticholinergic drug (e.g., atropine), cholinesterase-reactivating agents (e.g., oximes) and anticonvulsant drugs (e.g., benzodiazepines). Oximes, as a part of antidotal therapy, ensure the recovery of phosphylated enzymes via a process denoted as reactivation of inhibited AChE. However, both experimental results and clinical findings have demonstrated that different oximes are not equally effective against poisonings caused by structurally different organophosphorus compounds. Therefore, antidotal characteristics of conventionally used oximes can be evaluated regarding how close the certain substance is to the theoretical concept of the universal oxime. Pralidoxime (PAM-2), trimedoxime (TMB-4), obidoxime (LüH-6), HI-6 and HLö-7 have all been demonstrated to be very effective in experimental poisonings with sarin and VX. TMB-4 and LüH-6 may reactivate tabun-inhibited AChE, whereas HI-6 possesses the ability to reactivate the soman-inhibited enzyme. An oxime HLö-7 seems to be an efficient reactivator of AChE inhibited by any of the four organophosphorus warfare agents. According to the available literature, the oximes LüH-6 and TMB-4, although relatively toxic, are the most potent to induce reactivation of AChE inhibited by the majority of organophosphorus pesticides. Since there are no reports of controlled clinical trials on the use of TMB-4 in human organophosphate pesticide poisoning, LüH-6 may be a better option.
AuthorsBiljana Antonijevic, Milos P Stojiljkovic
JournalClinical medicine & research (Clin Med Res) Vol. 5 Issue 1 Pg. 71-82 (Mar 2007) ISSN: 1539-4182 [Print] United States
PMID17456837 (Publication Type: Journal Article, Review)
Chemical References
  • Antidotes
  • Chemical Warfare Agents
  • Cholinesterase Reactivators
  • Insecticides
  • Organothiophosphorus Compounds
  • Oximes
  • Pralidoxime Compounds
  • Obidoxime Chloride
  • Trimedoxime
  • VX
  • Sarin
  • Acetylcholinesterase
  • pralidoxime
Topics
  • Acetylcholinesterase (chemistry)
  • Antidotes
  • Chemical Warfare Agents (toxicity)
  • Cholinesterase Reactivators (administration & dosage, pharmacology)
  • Clinical Trials as Topic
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Insecticides (toxicity)
  • Obidoxime Chloride (chemistry)
  • Organophosphate Poisoning
  • Organothiophosphorus Compounds (toxicity)
  • Oximes (administration & dosage, chemistry, pharmacology)
  • Pralidoxime Compounds (chemistry)
  • Sarin (toxicity)
  • Trimedoxime (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: